IA
PDLI

Icon Advisers’s PDL BioPharma, Inc. PDLI Stock Holding History

Icon Advisers’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-109,373
Closed -$909K – 396
2014
Q1 		$909K Sell
109,373
-370,300
-77% -$3.17M 0.07% 213
2013
Q4 		$4.05M Sell
479,673
-24,400
-5% -$206K 0.29% 87
2013
Q3 		$4.02M Buy
504,073
+104,000
+26% +$836K 0.31% 82
2013
Q2 		$3.09M Buy
+400,073
New +$3.12M 0.24% 108

Other funds holding PDLI

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Icon Advisers's PDLI Position: Q2 2014 in Review

Icon Advisers sold out of PDL BioPharma, Inc. (PDLI) in Q2 2014, closing a stake of 109,373 shares — an estimated $909K sold.

Icon Advisers first reported a position in PDLI in Q2 2013 and held it in 4 quarters. The position peaked at $4.05M in Q4 2013. 222 funds tracked by Wall St. Rank hold PDLI as of Q2 2014.

  • Icon Advisers reported no remaining PDL BioPharma, Inc. position as of Q2 2014 after selling out during the quarter.
  • Icon Advisers sold 109,373 PDL BioPharma, Inc. shares in Q2 2014, an estimated $909K.
  • Icon Advisers first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 4 quarters.
  • Icon Advisers's PDL BioPharma, Inc. position peaked at $4.05M in Q4 2013.
  • 222 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2014.

Based on Icon Advisers's 13F filing for Q2 2014, filed 6 Aug 2014.